Induction of p21WAF/CIP1 during hyperoxia

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 2, 1998, Pages 179-187

  McGrath, Sharon A ^a,b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, MOUSE; CDKN1A PROTEIN, RAT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; MESSENGER RNA; PROTEIN P53;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL NUCLEUS; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; HYPEROXIA; LIVER; LUNG; METABOLISM; MOUSE; MOUSE MUTANT; NEWBORN; PHYSIOLOGY; RAT;

ANIMALS; ANIMALS, NEWBORN; CELL LINE; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPEROXIA; LIVER; LUNG; MICE; MICE, MUTANT STRAINS; RATS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031992345     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.2.2964m     Document Type: Article

References (41)

1. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 cdk-interacting protein CIP1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
2. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kohayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature (London) 366: 701-704.
3. El-Diery, W. S., T. Tokino, V. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. Kinder, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
4. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, M. P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
5. Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672-1677.
6. Elledge, S. J. 1996. Cell cycle checkpoints: preventing an identity crisis. Science 274:1664-1672.
7. Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266:1821-1828.
8. El-Diery, W. S., J. W. Harper, P. M. O'Connor, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Winman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein. 1994. WAF/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174.
9. Steinman, R. A., B. Hoffman, A. Iro, C. Guillouf, D. A. Liebermann, and M. E. El-Houseini. 1994. Induction of p21 (WAF-1/CIP) during differentiation. Oncogene 9:3389-3396.
10. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by myoD. Science 267:1018-1021.
11. O'Brodovich, H. M., and R. B. Mellins. 1985. Unresolved neonatal acute lung injury. Am. Rev. Respir. Dis. 132:694-709.
12. Erickson, A. M., S. M. de la Monte, G. W. Moore, and G. Hutchins. 1987. The progression of morphologic changes in bronchopulmonary dysplasia. Am. J. Pathol. 127:474-484.
13. Rush, M. G., and T. A. Hazinski. 1992. Current therapy of bronchopulmonary dysplasia. Clin. Perinatol. 19:563-590.
14. Frank, L. 1991. Developmental aspects of experimental pulmonary oxygen toxicity. Free Rad. Biol. Med. 2:463-494.
15. Kotecha, S., A. Wangoo, M. Silverman, and R. J. Shaw. 1996. Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of prematurity. J. Pediatr. 128:464-169.
16. Quinlan, T., S. Spivack, and B. T. Mossman. 1994. Regulation of antioxidant enzymes in lung after oxidant injury. Environ. Health Perspect. 102:79-87.
17. Yoo, J.-H., S. C. Erzurum, J. G. Hay, P. Lemarchand, and R. G. Crystal. 1994. Vulnerability of the human airway epithelium to hyperoxia. J. Clin. Invest. 93:297-302.
18. Cazals, V., B. Mouhieddine, B. Maitre, Y. Le Bouc, K. Chadelat, J. S. Brody, and A. Clements. 1994. Insulin-like growth factors, their binding proteins, and transforming growth factor-β 1 in oxidant-arrested lung alveolar epithelial cells. J. Biol. Chem. 209:14111-14117.
19. Kip, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
20. Toyoshima, H., and T. Hunter. 1994. p27. a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78:67-74.
21. Lee, P. J., J. Alam, S. L. Sylvester, N. Inamdar, L. Otterbein, and A. M. Choi. 1996. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am. J. Respir. Cell Mol. Biol. 14:556-568.
22. Horowitz, S., N. Dafni, D. L. Shapiro, B. A. Holm, R. H. Notter, and D. J. Quible. 1989. Hyperoxic exposure alters gene expression in the lung. J. Biol. Chem. 264:7092-7095.
23. Nici, L., R. Dowin, M. Gilmore-Hebert, D. Jamieson, and D. H. Ingbar. 1991. Upregulation of rat lung Na-K-ATPase during hyperoxic injury. Am. J. Physiol. 262:L307-L314.
24. + channel in the developing lung. Am. J. Physiol. 265:C491-C496.
25. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Extraction, purification and analysis of messenger RNA from eukaryotic cell. In Molecular Cloning: A Laboratory Manual. 2nd ed. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
26. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
27. Murray, J. F. 1986. Postnatal growth and development of the lung. In The Normal Lung: The Basis for Diagnosis and Treatment of Pulmonary Disease. 2nd ed. W.B. Saunders Co. Philadelphia, PA.
28. Jacks, T., and R. A. Weinberg. 1996. Cell-cycle control and its watchman. Nature (London) 381:643-644.
29. Oren, M., and C. Prives. 1996. p53: upstream, downstream and off stream. Review of the 8th p53 workshop. Biochim. Biophys. Acta 1288:R13-R19.
30. Gartel, A. L., M. S. Serfas, and A. L. Tyner. 1996. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:138-149.
31. CIP1 WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684.
32. Waldman, T., C. Lengauer, K. W. Kinzler, and B. Vogelstein. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature (London) 381:713-716.
33. Imlay, J. A., and S. Linn. 1988. DNA damage and oxygen radical toxicity. Science 240:1302-1309.
34. Crapo, J. D. 1986. Morphologic changes in pulmonary oxygen toxicity. Annu. Rev. Physiol. 48:721-731.
35. Graeber, T. G., C. Osmanian. T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe, and A. J. Giaccia. 1996. Hypoxia-mediated selection of cells with diminished apoptotie potential in solid tumors. Nature (London) 379:88-91.
36. Northway, W. H., R. C. Rosan, and D. Y. Porter. 1967. Pulmonary disease following respiratory therapy of hyaline membrane disease. N. Engl. J. Med. 276:357-368.
37. Wilson, W. L., M. Mullen, P. M. Olley, and M. Rabinovitch. 1985. Hyperoxia-induced pulmonary vascular and lung abnormalities in young rats and potential for recovery. Pediatr. Res. 19:1059-1067.
38. Randell, S. H., R. R. Mercer, and S. L. Young. 1990. Neonatal hyperoxia alters the pulmonary alveolar and capillary structure of 40-day-old rats. Amer. J. Pathol. 136:1259-1266.
39. Shaffer, S. G., D. O'Neil, S. K. Bradt, and D. W. Thibeault. 1987. Chronic vascular pulmonary dysplasia associated with neonatal hyperoxia exposure in the rat. Ped. Res. 21:14-20.
40. Northway, W. H., R. Petriceks, and L. Shahinian. 1972. Quantitative aspects of oxygen toxicity in the newborn: inhibition of lung DNA synthesis in the mouse. Pediatrics 49:67-72.
41. Marchetti, A., C. Doglioni, M. Barbareschi, F. Buttitta, S. Pellegrini, G. Bertacca, A. Chella, G. Merlo, A. Angeletti, P. Dalla Palma, and G. Bevilacqua. 1996. p21 RNA and protein expression in non-small cell lung carcinomas: evidence of p53-independent expression and association with tumoral differentiation. Oncogene 12:1319-1324.